CN Patent

CN111432806A — 包含沙芬酰胺的药物组合物

Assigned to Zambon SpA · Expires 2020-07-17 · 6y expired

What this patent protects

本发明涉及包含沙芬酰胺的药物组合物，且更具体地，本发明涉及包含所述活性成分或其药学上可接受的盐的掩味的颗粒、包括所述颗粒的口服剂型和它们的制备方法。

USPTO Abstract

本发明涉及包含沙芬酰胺的药物组合物，且更具体地，本发明涉及包含所述活性成分或其药学上可接受的盐的掩味的颗粒、包括所述颗粒的口服剂型和它们的制备方法。

Drugs covered by this patent

safinamide-mesylate (SAFINAMIDE MESYLATE)

Patent Metadata

Patent number: CN111432806A
Jurisdiction: CN
Classification: —
Expires: 2020-07-17
Drug substance claim: No
Drug product claim: No
Assignee: Zambon SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.